Ascendis Pharma As Stock Filter Stocks by Fundamentals
ASND Stock | USD 143.18 0.00 0.00% |
Ascendis Pharma AS fundamentals help investors to digest information that contributes to Ascendis Pharma's financial success or failures. It also enables traders to predict the movement of Ascendis Stock. The fundamental analysis module provides a way to measure Ascendis Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Ascendis Pharma stock.
Ascendis | Shares Owned by Institutions |
Ascendis Pharma Current Valuation Drivers
We derive many important indicators used in calculating different scores of Ascendis Pharma from analyzing Ascendis Pharma's financial statements. These drivers represent accounts that assess Ascendis Pharma's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Ascendis Pharma's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 5.7B | 6.9B | 6.5B | 6.4B | 6.4B | 6.7B | |
Enterprise Value | 5.2B | 6.4B | 6.2B | 6.5B | 6.7B | 7.0B |
Ascendis Pharma Institutional Holders
Institutional Holdings refers to the ownership stake in Ascendis Pharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Ascendis Pharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Ascendis Pharma's value.Shares | Franklin Resources Inc | 2023-12-31 | 1.1 M | Amvescap Plc. | 2023-12-31 | 907.9 K | Goldman Sachs Group Inc | 2023-12-31 | 845.7 K | Timessquare Capital Management, Llc | 2023-12-31 | 792.9 K | Sofinnova Ventures | 2023-12-31 | 754 K | Putnam Investments Llc | 2023-12-31 | 725.7 K | Vestal Point Capital Lp | 2023-12-31 | 625 K | Alliancebernstein L.p. | 2023-12-31 | 588.9 K | Spyglass Capital Management Llc | 2023-12-31 | 539.9 K | Ra Capital Management, Llc | 2023-12-31 | 10.1 M | Artisan Partners Limited Partnership | 2023-12-31 | 5.7 M |
Ascendis Fundamentals
Return On Equity | -8.18 | ||||
Return On Asset | -0.3 | ||||
Profit Margin | (1.81) % | ||||
Operating Margin | (0.27) % | ||||
Current Valuation | 8.44 B | ||||
Shares Outstanding | 56.61 M | ||||
Shares Owned By Insiders | 0.76 % | ||||
Shares Owned By Institutions | 99.24 % | ||||
Number Of Shares Shorted | 3.35 M | ||||
Price To Earning | (9.10) X | ||||
Price To Book | 14.55 X | ||||
Price To Sales | 31.00 X | ||||
Revenue | 266.72 M | ||||
Gross Profit | 39.04 M | ||||
EBITDA | (438.17 M) | ||||
Net Income | (481.45 M) | ||||
Cash And Equivalents | 955.15 M | ||||
Cash Per Share | 17.11 X | ||||
Total Debt | 644.26 M | ||||
Debt To Equity | 0.84 % | ||||
Current Ratio | 9.66 X | ||||
Book Value Per Share | (2.57) X | ||||
Cash Flow From Operations | (467.36 M) | ||||
Short Ratio | 10.88 X | ||||
Earnings Per Share | (9.11) X | ||||
Price To Earnings To Growth | 10.25 X | ||||
Target Price | 0.34 | ||||
Number Of Employees | 879 | ||||
Beta | 0.51 | ||||
Market Capitalization | 8.14 B | ||||
Total Asset | 825.59 M | ||||
Retained Earnings | (2.28 B) | ||||
Working Capital | 505.38 M | ||||
Current Asset | 125.65 M | ||||
Current Liabilities | 11.45 M | ||||
Net Asset | 825.59 M |
About Ascendis Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Ascendis Pharma AS's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ascendis Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ascendis Pharma AS based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ascendis Pharma Investors Sentiment
The influence of Ascendis Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ascendis. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Ascendis Pharma's public news can be used to forecast risks associated with an investment in Ascendis. The trend in average sentiment can be used to explain how an investor holding Ascendis can time the market purely based on public headlines and social activities around Ascendis Pharma AS. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Ascendis Pharma's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ascendis Pharma's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ascendis Pharma's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ascendis Pharma.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ascendis Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ascendis Pharma's short interest history, or implied volatility extrapolated from Ascendis Pharma options trading.
Pair Trading with Ascendis Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ascendis Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ascendis Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against Ascendis Stock
0.49 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
The ability to find closely correlated positions to Ascendis Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ascendis Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ascendis Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ascendis Pharma AS to buy it.
The correlation of Ascendis Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ascendis Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ascendis Pharma AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Ascendis Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Ascendis Pharma Piotroski F Score and Ascendis Pharma Altman Z Score analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Ascendis Stock analysis
When running Ascendis Pharma's price analysis, check to measure Ascendis Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascendis Pharma is operating at the current time. Most of Ascendis Pharma's value examination focuses on studying past and present price action to predict the probability of Ascendis Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascendis Pharma's price. Additionally, you may evaluate how the addition of Ascendis Pharma to your portfolios can decrease your overall portfolio volatility.
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Ascendis Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ascendis Pharma. If investors know Ascendis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ascendis Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.11) | Revenue Per Share 4.739 | Quarterly Revenue Growth 5.014 | Return On Assets (0.30) | Return On Equity (8.18) |
The market value of Ascendis Pharma AS is measured differently than its book value, which is the value of Ascendis that is recorded on the company's balance sheet. Investors also form their own opinion of Ascendis Pharma's value that differs from its market value or its book value, called intrinsic value, which is Ascendis Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ascendis Pharma's market value can be influenced by many factors that don't directly affect Ascendis Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ascendis Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Ascendis Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ascendis Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.